PT Pyridam Farma Tbk (PYFA.JK)
Jakarta · IDR · Healthcare · Drug Manufacturers - Specialty & Generic
IDR 147 (-6.37%) as of
Key statistics
- Market cap
- 1.65T
- EPS (TTM)
- -29.56
- Dividend yield
- 0.00%
- 52-week range
- 147.00 – 625.00
- Beta
- 0.82
- Revenue (TTM)
- 2.99T
- Profit margin
- -11.52%
- Volume
- 9.43M
About PT Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Jakarta Selatan, Indonesia
- Employees
- 2,463
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.